|
|
Post by babaoriley on Apr 6, 2016 15:09:12 GMT -5
Peppy, I had that Alan Sherman album when I was maybe 15 - really funny parodies! His head poking out of a bunch of nuts, if I recall, was the cover.
|
|
|
|
Post by mnkdorbust on Apr 6, 2016 15:13:11 GMT -5
Peppy, I had that Alan Sherman album when I was maybe 15 - really funny parodies! His head poking out of a bunch of nuts, if I recall, was the cover.  |
|
|
|
Post by stevil on Apr 6, 2016 15:53:56 GMT -5
gotcha. I wasn't saying that charts weren't useful. They can be used with other indicators to make an analysis. On their own, they're not worth much. That was the point I was trying to make.
|
|
|
|
Post by tayl5 on Apr 6, 2016 17:26:43 GMT -5
They are useful if enough other people believe they are useful.
|
|
|
|
Post by sportsrancho on Apr 6, 2016 18:33:23 GMT -5
You guys are funny with the technical analysis of this stock. Shorts covered due to Matt strong convictions that we were good on cash during the last conference call on top of a 100% borrow rate. People assumed there is a settlement and since no news broke people have started selling it and shorting it again. TA is fairly worthless with no news. What we saw was purely buy the rumor, sell the news. Unless Matt outlines how he plans on saving MNKD, it'll only be the ones with blind faith in him that hold their shares. The market as a whole doesn't have such faith. It's more like they are worthless on news. With no news the stock will keep trending back and forth between support and resistance. We get news, good or bad and it could gap up or down. Day traders use those lines. Because people use them they work over and over. I use charts to know when to buy or sell. You can make or save a little money that way:-) |
|
|
|
Post by uvula on Apr 6, 2016 18:56:18 GMT -5
Would you take investment advice from someone who invested in mnkd? I certainly wish I had not listened to myself.
|
|
|
|
Post by seanismorris on Apr 6, 2016 19:25:45 GMT -5
TA is useful for deciding when to make a trade.
If you've done a fundamental analysis and decided to buy a stock TA helps when deciding which day to buy in and maximize your investment. You might pick up a few percentage points in your favor...
On stocks like MNKD there is no fundamental analysis ...you can't look at profits or loses, growth, etc. All you have is a long term thesis. For example, rising diabetes rates around the world, then project out how big a piece of the pie (treating diabetes) Afrezza could capture. Basically we've been guessing and every long has been wrong.
With no news coming out of MannKind (that's market moving) but an investor (me) with a desire to own shares (trade) to take advantage of its volatility TA is the only way to go. Looking at the TA and price action of MNKD today, MNKD is setting up as a potential profitable trade. If I like what I see in the first two hours of trading tomorrow I'll be buying. And if the stock recovers, I'll be selling when it looks overextended.
If I do it correctly I could make 20% in a month (in this crazy stock).
There are many ways to invest, buying Long, Shorting, averaging in, options etc. do whatever works for you.
In response to the comment "TA is worthless with no news" I'd argue the opposite. MNKD has been sell the news. I don't want to day trade on news, I want a volatile range bound stock and news disrupts any pattern that I may find.
|
|
|
|
Post by seanismorris on Apr 6, 2016 19:39:48 GMT -5
Would you take investment advice from someone who invested in mnkd? I certainly wish I had not listened to myself. That depends on when you bought MNKD and sold. If you bought after the positive FDA adcom and sold after the poor Sanofi partnership you'd have done very well. Many did, but they are long gone from this forum. The problem is we convinced ourselves that it was a good deal when it wasn't. With MannKind's market cap at the time, Sanofi's outsized percentage of any profit, we should have known that MNKD would sell off. The next problem is was high expectations for Sanofi...but they were terrible in every regard. Investing in a Med company with no sales was always risky. Even the most ardent Longs admitted that... |
|
|
|
Post by sportsrancho on Apr 6, 2016 19:57:54 GMT -5
Oh we're not long gone:-) I bought 100 shares in 07. But went all in with 30,000 shares 8 months before approval at 2.00 per share. Still holding most of those shares. I added some at 3.00. But then waited till the stock was under a dollar and bought 400 1.50 2018 calls. Other calls at different prices. GL all.
|
|
|
|
Post by stevil on Apr 6, 2016 20:25:01 GMT -5
TA is useful for deciding when to make a trade. If you've done a fundamental analysis and decided to buy a stock TA helps when deciding which day to buy in and maximize your investment. You might pick up a few percentage points in your favor... On stocks like MNKD there is no fundamental analysis ...you can't look at profits or loses, growth, etc. All you have is a long term thesis. For example, rising diabetes rates around the world, then project out how big a piece of the pie (treating diabetes) Afrezza could capture. Basically we've been guessing and every long has been wrong. With no news coming out of MannKind (that's market moving) but an investor (me) with a desire to own shares (trade) to take advantage of its volatility TA is the only way to go. Looking at the TA and price action of MNKD today, MNKD is setting up as a potential profitable trade. If I like what I see in the first two hours of trading tomorrow I'll be buying. And if the stock recovers, I'll be selling when it looks overextended. If I do it correctly I could make 20% in a month (in this crazy stock). There are many ways to invest, buying Long, Shorting, averaging in, options etc. do whatever works for you. In response to the comment "TA is worthless with no news" I'd argue the opposite. MNKD has been sell the news. I don't want to day trade on news, I want a volatile range bound stock and news disrupts any pattern that I may find. In an attempt to save face, I agree with much, if not all, of what you stated above. I shouldn't have posted what I did because what I posted was incorrect and I'm far from an expert in TA. Having said all that, what I really meant to say was that with no news coming from Matt, that was actually what I would call "bad news". I think the technicals reflected that optimism and now (in my opinion) we'll be heading back downward... Hopefully things will change when we become oversold again, but I'm willing to bet that we won't see another solid wave up, if at all in the near term, until the next CC. But I'll tee this one up for my favorite crush and say that I'll stop posting in this thread before I make an (even bigger) ass of myself. |
|
|
|
Post by trenddiver on Apr 7, 2016 1:34:25 GMT -5
Trend, Whats your thought on today's action? Did you get stopped out when the pps dipped to $1.32? Is the sell off on essentially what was another non event news yesterday. There certainly has not been a shortage of hit pieces lately. Interest to borrow shares has gone up again. The shorts are still at it. I was out playing golf so I kinda missed today's action. Like i said in earlier posts, the price went from .67 to 2.25 on no news so why shouldn't it retreat on no news. The only addition I have to my most recent comments is that the 20 day moving average (which provided support on the way up) is at 1.67 while the SP is at 1.47. This could provide resistance to any price increases. The 50 day moving average is at $1.28, which should provide additional support. As I said before, MNKD has broken through significant resistance on the way up in the $1.50 area which it is now testing as support. Hopefully the price will consolidate at these levels in preparation for the next move up. I will update my technical analysis perspective after the market closes on Friday. Trend |
|
|
|
Post by LosingMyBullishness on Apr 7, 2016 9:08:16 GMT -5
I would not have such a big problem to sell now and buy back at 0.67 if I knew if and when MNKD publishes that they have a partner for distribution, a marketing strategy and a fixed timing for roll-out and new pricing. Would have loved to hear this in the PR although I did not expected it.
|
|
|
|
Post by sf1981 on Apr 7, 2016 9:12:19 GMT -5
I would not have such a big problem to sell now and buy back at 0.67 if I knew if and when MNKD publishes that they have a partner for distribution, a marketing strategy and a fixed timing for roll-out and new pricing. Would have loved to hear this in the PR although I did not expected it. Hey, that's my plan as well! Why do I have this feeling that it is not going to be as easy....  ) |
|
|
|
Post by coo2002coo on Apr 7, 2016 9:25:54 GMT -5
If we look at the weekly chart, MNKD correction is far from over. $1.00 level is likely to be tested again.
|
|
|
|
Post by peppy on Apr 7, 2016 10:10:55 GMT -5
If we look at the weekly chart, MNKD correction is far from over. $1.00 level is likely to be tested again. coocoo you know how I have been looking out like crazy for some sign of a change of trend. look intraday. seller gone. price hit yesterday was close to the .618. price holding so far today an inside day. the spx lost it's floor, (intraday) MNKD: the daily looks like hell, the weekly looks like hell, the monthly looks like hell. Napalm.
|
|
)
